FOXP3 and colitis: Treatment with analogue 5 elevated the percentage of CD25+FoxP3+ Treg in MLN CD4 lymphocytes of mice with TNBS- and DSS-induced colitis (Fig. 6c and Supplementary Fig. 6d).